Overview
STAA market data
Price History
STAA price chart · 1M
- O
- 22.78
- H
- 22.80
- L
- 22.33
- C
- 22.39
- Vol
- 30,639.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $22.78
- Previous Close
- $22.83
- Day High
- $22.80
- Day Low
- $22.33
- 52 Week High
- $35.70
- 52 Week Low
- $21.35
- 7 Day Return
- -2.95%
- 30 Day Return
- -1.21%
- 90 Day Return
- -25.14%
- 1 Year Return
- -12.09%
- Daily Notional Volume
- $686K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.62 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.19 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -7.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $15.59 – $35.87 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.3B · P/B 3.41 · P/S 4.36.
Company News
Staar Surgical shares are trading lower after Stifel lowered its price target on the stock from $31 to $28.Benzinga · Aug 17, 2026, 4:27 PM
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28Benzinga · Aug 17, 2026, 11:51 AM
UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19Benzinga · Aug 13, 2026, 9:15 PM
Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37Benzinga · Aug 13, 2026, 12:58 PM
Staar Surgical Q2 EPS $0.16 Beats $0.15 Estimate, Sales $93.535M Beat $90.589M EstimateBenzinga · Aug 12, 2026, 8:02 PM
8-K filing — STAAR SURGICAL CO (STAA)SEC EDGAR · Aug 6, 2026, 3:04 PM
STAAR Surgical Appoints Warren Foust As President And CEO, Effective August 4; Names Deborah Andrews EVP And CFOBenzinga · Aug 4, 2026, 8:35 PM
Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price TargetBenzinga · Aug 4, 2026, 12:55 PM
STAAR Surgical shares are trading lower. The company reported Q2 preliminary results.Benzinga · Jul 17, 2026, 12:54 PM
Caution Lingers for STAAR Surgical Amid Middle East Geopolitical TensionsBenzinga · Jul 17, 2026, 12:41 PM